Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Brian Moore who wrote (17634)	3/18/1998 7:22:00 PM
From: celeryroot.com	Read Replies (1) \| Respond to of 32384

Brian, I take it you are new to Biotech investing. If you wait for a profit in Bio's you've waited to long. There are numerous articles explaining.

To: Brian Moore who wrote (17634)	3/18/1998 8:00:00 PM
From: Hippieslayer	Read Replies (1) \| Respond to of 32384

I agree with you to a point. In the whole realm of "stocks", lgnd takes a back seat to other companies in other industries that are not determined by the approval of regulatory committees such as the FDA. But, if you are looking at biotechs in particular, Lgnd has to be one of the best picks out there. There is a lot of risk to lgnd. I don't want anyone to think that there isn't. But, there is less risk to lgnd in comparison to a lot of other biotechs out there. Why? Look at the number of partners; number of drugs in the pipeline; the distance and clinical success that their lead drugs have gone (ie Panretin and Targretin) and the level of management. These facts alone will not guarantee that LGND will be successful as a company, but the crucial pieces of the puzzle are in place to make lgnd a successful company, imho. And you are right to state that lgnd isn't making any money because, at the moment, they aren't making one red cent. The hope is that if and when their drugs are approved and their drugs are heavily used because they work so well, lgnd will be a cash cow and will have a growth rate many companies could only dream of having. Having a deep pipeline of drugs will help LGND, in theory, maintain a nice growth level by introducing new drugs every 3 or 4 years(which might be highly speculative on my part). Lgnd needs to get a NDA for their first drug. From there, things will look a lot different for this stock.

To: Brian Moore who wrote (17634)	3/18/1998 8:05:00 PM
From: tonyt	Read Replies (2) \| Respond to of 32384

Don't lose sight of the fact that LGND is an excellent trading stock. As long as one doesn't get 'piggy' waiting for triple digits (i.e. CTSL had a target of $100 for '98), a ton of money can be made here. Good luck! --Tony

To: Brian Moore who wrote (17634)	3/19/1998 2:54:00 AM
From: HerbertOtto	Read Replies (2) \| Respond to of 32384

Brian, After reading your un-informed ideas of investing, let me suggest you begin with an easy-to-understand book by William J. O'Neil, "How to Make Money in Stocks". O'Neil is the founder of Investor's Daily. This will help you overcome your University views of investing - which generally lead to 'buy at the top' from Wall Street analysts. Let me also suggest you might try some simpler investments - other than biotechs. As you point out - no earnings - doesn't quite fit the simple University view of investing. You might try either Home Depot - a proven winner, or Eagle Hardware - a determined newcomer. Both companies have great sales and earnings histories. And you can take your choice of the established leader, or the profitable upstart. Both companies have all the numbers you need for your models. And you don't need the faith in science and research that is necessary for a biotech investor. Good luck, Herbert